Cornerstone Capital Management Holdings’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | $345K | Buy |
6,471
+100
| +2% | +$5.33K | ﹤0.01% | 1062 |
|
2017
Q3 | $379K | Buy |
6,371
+300
| +5% | +$17.8K | ﹤0.01% | 1094 |
|
2017
Q2 | $478K | Sell |
6,071
-105
| -2% | -$8.27K | ﹤0.01% | 1045 |
|
2017
Q1 | $511K | Buy |
+6,176
| New | +$511K | ﹤0.01% | 1057 |
|
2015
Q4 | – | Sell |
-1,000
| Closed | -$74K | – | 1556 |
|
2015
Q3 | $74K | Buy |
+1,000
| New | +$74K | ﹤0.01% | 1369 |
|